Lung Disease Chronic
Conditions
Keywords
Walking, Exoskeleton Device
Brief summary
Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy demands of walking causing them to walk slowly and stop often. Those with CRD could receive substantial benefit from a powered wearable exoskeleton device that assumes part of the energy of walking. Assisting the legs will lower the metabolic energy demands, and therefore the ventilation required for exercise, thereby allowing them to walk faster and further. Proposed is a series of single-case experiments comparing walking endurance with and without a powered hip exoskeleton assist. The aim of this study is to determine the efficacy of an exoskeleton on walking endurance in ventilatory limited patients with CRD. An exoskeleton could be a novel immediate and long term strategy to augment walking as part of the spectrum of pulmonary rehabilitation and community reintegration.
Interventions
DEVICEexoskeleton assist
A powered exoskeleton describes a wearable robot designed around the shape and function of the human body with segments and joints externally coupled to those of the user. The exoskeleton includes a rigid outer frame, sensors that detect a user's desired movements, a computerized controller, motors and actuators, and lightweight batteries. The exoskeleton is designed to be worn in the community.
Sponsors
West Park Healthcare Centre
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
A prospective longitudinal, self-controlled, single-case repeated measures alternating treatment, randomized and counterbalanced cross-over experimental trial design, comparing walking endurance without and with a powered exoskeleton.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* stable chronic respiratory disease * modified medical research council dyspnoea score (mMRC) ≥ 2
Exclusion criteria
* evidence of cardiac rhythm or circulatory compromise * myocardial infarct within the previous three months * moderate-severe aortic stenosis * uncontrolled hypertension * sustained cardiac arrhythmias * untreated neoplasia * lung surgery within the previous three months * any other predominant co-morbidities or treatments that might influence walk testing * body size outside of exoskeleton fit specifications * skin sores or skin breakdown in the area where the device is worn * a high risk of fracture
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| walking endurance time | an average of 7 tests over 4 weeks | tolerance (time) of an individualized constant, brisk, walking speed endurance test |
Countries
Canada
Contacts
PRINCIPAL_INVESTIGATORRoger Goldstein
West Park Healthcare Centre
Outcome results
None listed